US2013217694A1PendingUtilityA1
Method of reducing the severity of inflammatory dermatological conditions
Est. expiryJun 25, 2023(expired)· nominal 20-yr term from priority
A61P 3/10A61P 37/08A61P 29/00A61P 25/00A61P 25/14A61P 25/06A61P 21/00A61P 13/10A61P 11/00A61P 1/14A61K 31/498A61P 1/00A61P 1/04A61P 17/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method of reducing the severity of one or more symptoms of an inflammatory dermatological condition in a subject, comprising topically administering to the skin of a subject in need of such reduction an effective amount of brimonidine or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of reducing the severity of one or more symptoms of an inflammatory dermatological condition in a subject, the method comprising topically administering to the skin of a subject in need of such reduction an effective amount of brimonidine or a pharmaceutically acceptable salt, ester, amide, stereoisomer or racemic mixture thereof.
2 . The method of claim 1 , wherein the method comprises topically administering brimonidine tartrate.Join the waitlist — get patent alerts
Track US2013217694A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.